nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Sorafenib—liver cancer	0.104	0.389	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—liver cancer	0.0633	0.236	CbGbCtD
Methylprednisolone—CYP3A4—Sorafenib—liver cancer	0.0625	0.233	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—liver cancer	0.0379	0.141	CbGbCtD
Methylprednisolone—Embolism venous—Epirubicin—liver cancer	0.004	0.00734	CcSEcCtD
Methylprednisolone—Hypernatraemia—Epirubicin—liver cancer	0.00384	0.00705	CcSEcCtD
Methylprednisolone—Mood swings—Sorafenib—liver cancer	0.00376	0.0069	CcSEcCtD
Methylprednisolone—Embolism venous—Doxorubicin—liver cancer	0.0037	0.00679	CcSEcCtD
Methylprednisolone—Blindness—Epirubicin—liver cancer	0.00365	0.00669	CcSEcCtD
Methylprednisolone—Breast disorder—Sorafenib—liver cancer	0.00358	0.00658	CcSEcCtD
Methylprednisolone—Hypernatraemia—Doxorubicin—liver cancer	0.00355	0.00652	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Sorafenib—liver cancer	0.0035	0.00642	CcSEcCtD
Methylprednisolone—Skin hyperpigmentation—Epirubicin—liver cancer	0.00339	0.00623	CcSEcCtD
Methylprednisolone—Blindness—Doxorubicin—liver cancer	0.00337	0.00619	CcSEcCtD
Methylprednisolone—Pancreatitis—Sorafenib—liver cancer	0.00336	0.00617	CcSEcCtD
Methylprednisolone—Optic neuritis—Epirubicin—liver cancer	0.00328	0.00602	CcSEcCtD
Methylprednisolone—Folliculitis—Epirubicin—liver cancer	0.00321	0.0059	CcSEcCtD
Methylprednisolone—Embolism—Epirubicin—liver cancer	0.00314	0.00577	CcSEcCtD
Methylprednisolone—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00314	0.00576	CcSEcCtD
Methylprednisolone—Infestation NOS—Sorafenib—liver cancer	0.00306	0.00561	CcSEcCtD
Methylprednisolone—Infestation—Sorafenib—liver cancer	0.00306	0.00561	CcSEcCtD
Methylprednisolone—Optic neuritis—Doxorubicin—liver cancer	0.00304	0.00557	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Sorafenib—liver cancer	0.00301	0.00553	CcSEcCtD
Methylprednisolone—Myocardial infarction—Sorafenib—liver cancer	0.003	0.0055	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Sorafenib—liver cancer	0.003	0.0055	CcSEcCtD
Methylprednisolone—Folliculitis—Doxorubicin—liver cancer	0.00297	0.00546	CcSEcCtD
Methylprednisolone—Embolism—Doxorubicin—liver cancer	0.00291	0.00534	CcSEcCtD
Methylprednisolone—Hypercalcaemia—Epirubicin—liver cancer	0.00291	0.00533	CcSEcCtD
Methylprednisolone—Hepatomegaly—Epirubicin—liver cancer	0.00285	0.00524	CcSEcCtD
Methylprednisolone—Haemoglobin—Sorafenib—liver cancer	0.00276	0.00506	CcSEcCtD
Methylprednisolone—Haemorrhage—Sorafenib—liver cancer	0.00274	0.00504	CcSEcCtD
Methylprednisolone—Neuritis—Epirubicin—liver cancer	0.0027	0.00496	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Sorafenib—liver cancer	0.0027	0.00495	CcSEcCtD
Methylprednisolone—Hypercalcaemia—Doxorubicin—liver cancer	0.00269	0.00494	CcSEcCtD
Methylprednisolone—Hepatomegaly—Doxorubicin—liver cancer	0.00264	0.00484	CcSEcCtD
Methylprednisolone—Fungal infection—Epirubicin—liver cancer	0.00261	0.0048	CcSEcCtD
Methylprednisolone—Necrosis—Epirubicin—liver cancer	0.00257	0.00472	CcSEcCtD
Methylprednisolone—Abscess—Epirubicin—liver cancer	0.00255	0.00468	CcSEcCtD
Methylprednisolone—Cardiac disorder—Sorafenib—liver cancer	0.00255	0.00467	CcSEcCtD
Methylprednisolone—Neuritis—Doxorubicin—liver cancer	0.0025	0.00459	CcSEcCtD
Methylprednisolone—Glycosuria—Epirubicin—liver cancer	0.00249	0.00457	CcSEcCtD
Methylprednisolone—Angiopathy—Sorafenib—liver cancer	0.00249	0.00457	CcSEcCtD
Methylprednisolone—Immune system disorder—Sorafenib—liver cancer	0.00248	0.00455	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Sorafenib—liver cancer	0.00247	0.00454	CcSEcCtD
Methylprednisolone—Petechiae—Epirubicin—liver cancer	0.00245	0.0045	CcSEcCtD
Methylprednisolone—Arrhythmia—Sorafenib—liver cancer	0.00245	0.0045	CcSEcCtD
Methylprednisolone—Fungal infection—Doxorubicin—liver cancer	0.00242	0.00444	CcSEcCtD
Methylprednisolone—Mental disorder—Sorafenib—liver cancer	0.0024	0.00441	CcSEcCtD
Methylprednisolone—Malnutrition—Sorafenib—liver cancer	0.00239	0.00438	CcSEcCtD
Methylprednisolone—Erythema—Sorafenib—liver cancer	0.00239	0.00438	CcSEcCtD
Methylprednisolone—Necrosis—Doxorubicin—liver cancer	0.00238	0.00437	CcSEcCtD
Methylprednisolone—Abscess—Doxorubicin—liver cancer	0.00236	0.00433	CcSEcCtD
Methylprednisolone—Glycosuria—Doxorubicin—liver cancer	0.00231	0.00423	CcSEcCtD
Methylprednisolone—Amenorrhoea—Epirubicin—liver cancer	0.0023	0.00422	CcSEcCtD
Methylprednisolone—Petechiae—Doxorubicin—liver cancer	0.00227	0.00417	CcSEcCtD
Methylprednisolone—Arthropathy—Epirubicin—liver cancer	0.00222	0.00408	CcSEcCtD
Methylprednisolone—Angioedema—Sorafenib—liver cancer	0.00218	0.00401	CcSEcCtD
Methylprednisolone—Syncope—Sorafenib—liver cancer	0.00214	0.00393	CcSEcCtD
Methylprednisolone—Amenorrhoea—Doxorubicin—liver cancer	0.00213	0.0039	CcSEcCtD
Methylprednisolone—Loss of consciousness—Sorafenib—liver cancer	0.0021	0.00385	CcSEcCtD
Methylprednisolone—Inflammation—Epirubicin—liver cancer	0.00208	0.00382	CcSEcCtD
Methylprednisolone—Hypertension—Sorafenib—liver cancer	0.00206	0.00378	CcSEcCtD
Methylprednisolone—Arthropathy—Doxorubicin—liver cancer	0.00205	0.00377	CcSEcCtD
Methylprednisolone—Arthralgia—Sorafenib—liver cancer	0.00203	0.00373	CcSEcCtD
Methylprednisolone—Myalgia—Sorafenib—liver cancer	0.00203	0.00373	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00202	0.00371	CcSEcCtD
Methylprednisolone—Hiccups—Epirubicin—liver cancer	0.00202	0.00371	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Sorafenib—liver cancer	0.00195	0.00358	CcSEcCtD
Methylprednisolone—Infection—Sorafenib—liver cancer	0.00194	0.00355	CcSEcCtD
Methylprednisolone—Skin exfoliation—Epirubicin—liver cancer	0.00193	0.00354	CcSEcCtD
Methylprednisolone—Inflammation—Doxorubicin—liver cancer	0.00193	0.00354	CcSEcCtD
Methylprednisolone—Shock—Sorafenib—liver cancer	0.00192	0.00352	CcSEcCtD
Methylprednisolone—Fluid retention—Epirubicin—liver cancer	0.00192	0.00352	CcSEcCtD
Methylprednisolone—Nervous system disorder—Sorafenib—liver cancer	0.00191	0.00351	CcSEcCtD
Methylprednisolone—Neuropathy—Epirubicin—liver cancer	0.0019	0.00348	CcSEcCtD
Methylprednisolone—Skin disorder—Sorafenib—liver cancer	0.00189	0.00347	CcSEcCtD
Methylprednisolone—Hiccups—Doxorubicin—liver cancer	0.00187	0.00343	CcSEcCtD
Methylprednisolone—Oesophagitis—Epirubicin—liver cancer	0.00184	0.00339	CcSEcCtD
Methylprednisolone—Ecchymosis—Epirubicin—liver cancer	0.00183	0.00335	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Epirubicin—liver cancer	0.0018	0.0033	CcSEcCtD
Methylprednisolone—Skin exfoliation—Doxorubicin—liver cancer	0.00178	0.00327	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00178	0.00326	CcSEcCtD
Methylprednisolone—Fluid retention—Doxorubicin—liver cancer	0.00177	0.00326	CcSEcCtD
Methylprednisolone—Neuropathy—Doxorubicin—liver cancer	0.00175	0.00322	CcSEcCtD
Methylprednisolone—Dyspepsia—Sorafenib—liver cancer	0.00172	0.00315	CcSEcCtD
Methylprednisolone—Oesophagitis—Doxorubicin—liver cancer	0.00171	0.00313	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Epirubicin—liver cancer	0.00169	0.00311	CcSEcCtD
Methylprednisolone—Ecchymosis—Doxorubicin—liver cancer	0.00169	0.0031	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Epirubicin—liver cancer	0.00168	0.00309	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00168	0.00309	CcSEcCtD
Methylprednisolone—Fatigue—Sorafenib—liver cancer	0.00168	0.00308	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Doxorubicin—liver cancer	0.00166	0.00305	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Epirubicin—liver cancer	0.00162	0.00297	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Sorafenib—liver cancer	0.00159	0.00293	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Doxorubicin—liver cancer	0.00157	0.00288	CcSEcCtD
Methylprednisolone—Increased appetite—Epirubicin—liver cancer	0.00156	0.00286	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00156	0.00286	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Doxorubicin—liver cancer	0.00156	0.00286	CcSEcCtD
Methylprednisolone—Urticaria—Sorafenib—liver cancer	0.00155	0.00284	CcSEcCtD
Methylprednisolone—Abdominal pain—Sorafenib—liver cancer	0.00154	0.00283	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Epirubicin—liver cancer	0.00151	0.00278	CcSEcCtD
Methylprednisolone—Cardiac failure—Epirubicin—liver cancer	0.0015	0.00276	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Doxorubicin—liver cancer	0.0015	0.00274	CcSEcCtD
Methylprednisolone—Osteoarthritis—Epirubicin—liver cancer	0.00147	0.00269	CcSEcCtD
Methylprednisolone—Increased appetite—Doxorubicin—liver cancer	0.00144	0.00265	CcSEcCtD
Methylprednisolone—Affect lability—Epirubicin—liver cancer	0.00144	0.00265	CcSEcCtD
Methylprednisolone—Hypersensitivity—Sorafenib—liver cancer	0.00144	0.00264	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.0014	0.00257	CcSEcCtD
Methylprednisolone—Asthenia—Sorafenib—liver cancer	0.0014	0.00257	CcSEcCtD
Methylprednisolone—Cardiac arrest—Epirubicin—liver cancer	0.00139	0.00256	CcSEcCtD
Methylprednisolone—Cardiac failure—Doxorubicin—liver cancer	0.00139	0.00255	CcSEcCtD
Methylprednisolone—Mood swings—Epirubicin—liver cancer	0.00139	0.00255	CcSEcCtD
Methylprednisolone—Pruritus—Sorafenib—liver cancer	0.00138	0.00253	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—liver cancer	0.00136	0.00249	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—liver cancer	0.00133	0.00245	CcSEcCtD
Methylprednisolone—Diarrhoea—Sorafenib—liver cancer	0.00133	0.00245	CcSEcCtD
Methylprednisolone—Breast disorder—Epirubicin—liver cancer	0.00132	0.00243	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00129	0.00237	CcSEcCtD
Methylprednisolone—Muscular weakness—Epirubicin—liver cancer	0.00129	0.00237	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—liver cancer	0.00129	0.00237	CcSEcCtD
Methylprednisolone—Dizziness—Sorafenib—liver cancer	0.00129	0.00237	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—liver cancer	0.00128	0.00236	CcSEcCtD
Methylprednisolone—Abdominal distension—Epirubicin—liver cancer	0.00128	0.00234	CcSEcCtD
Methylprednisolone—Pancreatitis—Epirubicin—liver cancer	0.00124	0.00228	CcSEcCtD
Methylprednisolone—Vomiting—Sorafenib—liver cancer	0.00124	0.00227	CcSEcCtD
Methylprednisolone—Rash—Sorafenib—liver cancer	0.00123	0.00226	CcSEcCtD
Methylprednisolone—Dermatitis—Sorafenib—liver cancer	0.00123	0.00225	CcSEcCtD
Methylprednisolone—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00123	0.00662	CbGpPWpGaD
Methylprednisolone—Breast disorder—Doxorubicin—liver cancer	0.00123	0.00225	CcSEcCtD
Methylprednisolone—Headache—Sorafenib—liver cancer	0.00122	0.00224	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptors—PPARG—liver cancer	0.00121	0.0065	CbGpPWpGaD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.0012	0.0022	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—liver cancer	0.0012	0.0022	CcSEcCtD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00118	0.00637	CbGpPWpGaD
Methylprednisolone—Abdominal distension—Doxorubicin—liver cancer	0.00118	0.00217	CcSEcCtD
Methylprednisolone—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00117	0.00633	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—AHR—liver cancer	0.00116	0.00628	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.00116	0.00626	CbGpPWpGaD
Methylprednisolone—Nausea—Sorafenib—liver cancer	0.00116	0.00213	CcSEcCtD
Methylprednisolone—Weight increased—Epirubicin—liver cancer	0.00115	0.00212	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00115	0.00622	CbGpPWpGaD
Methylprednisolone—Pancreatitis—Doxorubicin—liver cancer	0.00115	0.00211	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—liver cancer	0.00113	0.00207	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—liver cancer	0.00113	0.00207	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—liver cancer	0.00111	0.00598	CbGpPWpGaD
Methylprednisolone—Neuropathy peripheral—Epirubicin—liver cancer	0.00111	0.00203	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—IL12A—liver cancer	0.0011	0.00591	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—PPARA—liver cancer	0.00108	0.00585	CbGpPWpGaD
Methylprednisolone—Sweating—Epirubicin—liver cancer	0.00108	0.00199	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—liver cancer	0.00107	0.00196	CcSEcCtD
Methylprednisolone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00105	0.00569	CbGpPWpGaD
Methylprednisolone—Infestation—Doxorubicin—liver cancer	0.00104	0.00192	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—liver cancer	0.00104	0.00192	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00104	0.00563	CbGpPWpGaD
Methylprednisolone—Bradycardia—Epirubicin—liver cancer	0.00103	0.00189	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.00103	0.00557	CbGpPWpGaD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—liver cancer	0.00102	0.00188	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.00102	0.0055	CbGpPWpGaD
Methylprednisolone—Haemoglobin—Epirubicin—liver cancer	0.00102	0.00187	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—liver cancer	0.00102	0.00187	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—liver cancer	0.00101	0.00186	CcSEcCtD
Methylprednisolone—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00101	0.00546	CbGpPWpGaD
Methylprednisolone—Sweating—Doxorubicin—liver cancer	0.001	0.00184	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—liver cancer	0.000996	0.00183	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.000991	0.00535	CbGpPWpGaD
Methylprednisolone—Visual impairment—Epirubicin—liver cancer	0.000977	0.00179	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.000964	0.0052	CbGpPWpGaD
Methylprednisolone—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000959	0.00517	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.000959	0.00517	CbGpPWpGaD
Methylprednisolone—Bradycardia—Doxorubicin—liver cancer	0.000955	0.00175	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.000952	0.00514	CbGpPWpGaD
Methylprednisolone—Eye disorder—Epirubicin—liver cancer	0.000947	0.00174	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—liver cancer	0.000943	0.00173	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—liver cancer	0.000941	0.00173	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—liver cancer	0.00094	0.00173	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—liver cancer	0.000938	0.00172	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000936	0.00505	CbGpPWpGaD
Methylprednisolone—Connective tissue disorder—Doxorubicin—liver cancer	0.000922	0.00169	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—liver cancer	0.00092	0.00169	CcSEcCtD
Methylprednisolone—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000919	0.00496	CbGpPWpGaD
Methylprednisolone—Immune system disorder—Epirubicin—liver cancer	0.000916	0.00168	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—liver cancer	0.000914	0.00168	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—liver cancer	0.000906	0.00166	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—liver cancer	0.000904	0.00166	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.000899	0.00485	CbGpPWpGaD
Methylprednisolone—Mental disorder—Epirubicin—liver cancer	0.000888	0.00163	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—liver cancer	0.000883	0.00162	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—liver cancer	0.000883	0.00162	CcSEcCtD
Methylprednisolone—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000882	0.00476	CbGpPWpGaD
Methylprednisolone—Eye disorder—Doxorubicin—liver cancer	0.000877	0.00161	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—liver cancer	0.000871	0.0016	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000856	0.00462	CbGpPWpGaD
Methylprednisolone—Angiopathy—Doxorubicin—liver cancer	0.000851	0.00156	CcSEcCtD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000848	0.00457	CbGpPWpGaD
Methylprednisolone—Immune system disorder—Doxorubicin—liver cancer	0.000847	0.00156	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—liver cancer	0.000845	0.00155	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—liver cancer	0.000838	0.00154	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—liver cancer	0.000822	0.00151	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—liver cancer	0.000819	0.0015	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—liver cancer	0.000817	0.0015	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—liver cancer	0.000817	0.0015	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.00081	0.00437	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.000808	0.00436	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000803	0.00433	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.0008	0.00431	CbGpPWpGaD
Methylprednisolone—Malaise—Epirubicin—liver cancer	0.000796	0.00146	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—liver cancer	0.000793	0.00146	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—liver cancer	0.000791	0.00145	CcSEcCtD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.000784	0.00423	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—APC—liver cancer	0.000784	0.00423	CbGpPWpGaD
Methylprednisolone—Loss of consciousness—Epirubicin—liver cancer	0.000776	0.00142	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—liver cancer	0.000765	0.0014	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—liver cancer	0.000762	0.0014	CcSEcCtD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000758	0.00409	CbGpPWpGaD
Methylprednisolone—Ill-defined disorder—Doxorubicin—liver cancer	0.000758	0.00139	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—liver cancer	0.000751	0.00138	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—liver cancer	0.000751	0.00138	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—liver cancer	0.000749	0.00137	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000746	0.00137	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—liver cancer	0.000742	0.00136	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—liver cancer	0.000736	0.00135	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—liver cancer	0.000734	0.00135	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—liver cancer	0.000732	0.00134	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.000728	0.00393	CbGpPWpGaD
Methylprednisolone—Confusional state—Epirubicin—liver cancer	0.000726	0.00133	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.000721	0.00389	CbGpPWpGaD
Methylprednisolone—Anaphylactic shock—Epirubicin—liver cancer	0.00072	0.00132	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—liver cancer	0.000718	0.00132	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—liver cancer	0.000716	0.00131	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—liver cancer	0.000709	0.0013	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000708	0.00382	CbGpPWpGaD
Methylprednisolone—Convulsion—Doxorubicin—liver cancer	0.000707	0.0013	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—liver cancer	0.000706	0.0013	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—liver cancer	0.000705	0.00129	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—liver cancer	0.000703	0.00129	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—liver cancer	0.0007	0.00128	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—liver cancer	0.000696	0.00128	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—liver cancer	0.000695	0.00128	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—liver cancer	0.000695	0.00128	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—liver cancer	0.000693	0.00127	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00069	0.00127	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—UGDH—liver cancer	0.00069	0.00372	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL12B—liver cancer	0.000688	0.00371	CbGpPWpGaD
Methylprednisolone—Discomfort—Doxorubicin—liver cancer	0.000687	0.00126	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—liver cancer	0.000673	0.00124	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—liver cancer	0.000672	0.00123	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—liver cancer	0.000666	0.00122	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—liver cancer	0.000662	0.00122	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000656	0.0012	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—liver cancer	0.000656	0.0012	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.000655	0.00353	CbGpPWpGaD
Methylprednisolone—Nervous system disorder—Doxorubicin—liver cancer	0.000654	0.0012	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—liver cancer	0.000651	0.0012	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—liver cancer	0.00065	0.00119	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—liver cancer	0.000647	0.00119	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—liver cancer	0.000647	0.00119	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—liver cancer	0.000644	0.00118	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—liver cancer	0.000634	0.00116	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00063	0.0034	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.000623	0.00336	CbGpPWpGaD
Methylprednisolone—Hypotension—Doxorubicin—liver cancer	0.000623	0.00114	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.000622	0.00335	CbGpPWpGaD
Methylprednisolone—Fatigue—Epirubicin—liver cancer	0.000621	0.00114	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00062	0.00334	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000607	0.00111	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—liver cancer	0.000603	0.00111	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—liver cancer	0.000598	0.0011	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—liver cancer	0.000594	0.00109	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.000593	0.0032	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Epirubicin—liver cancer	0.000589	0.00108	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—liver cancer	0.000587	0.00108	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—liver cancer	0.000575	0.00105	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—liver cancer	0.000572	0.00105	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—liver cancer	0.000569	0.00105	CcSEcCtD
Methylprednisolone—Clobetasol propionate—CYP1A1—liver cancer	0.000557	0.329	CrCbGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.000556	0.003	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.000551	0.00297	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Doxorubicin—liver cancer	0.000549	0.00101	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.000547	0.00295	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARA—liver cancer	0.000545	0.00294	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000545	0.001	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000539	0.00291	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000539	0.00291	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.000539	0.00291	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.000533	0.00287	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Epirubicin—liver cancer	0.000531	0.000974	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—liver cancer	0.000529	0.000972	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000528	0.00285	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000527	0.00284	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Doxorubicin—liver cancer	0.000527	0.000967	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.000525	0.00283	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.000524	0.00283	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.00052	0.00281	CbGpPWpGaD
Methylprednisolone—Asthenia—Epirubicin—liver cancer	0.000517	0.000949	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000512	0.00276	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.00051	0.00275	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00051	0.00275	CbGpPWpGaD
Methylprednisolone—Pruritus—Epirubicin—liver cancer	0.00051	0.000935	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000503	0.00271	CbGpPWpGaD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—liver cancer	0.000494	0.292	CrCbGaD
Methylprednisolone—Diarrhoea—Epirubicin—liver cancer	0.000493	0.000905	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—liver cancer	0.000491	0.000901	CcSEcCtD
Methylprednisolone—Asthenia—Doxorubicin—liver cancer	0.000478	0.000878	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—liver cancer	0.000476	0.000874	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.000475	0.00256	CbGpPWpGaD
Methylprednisolone—Pruritus—Doxorubicin—liver cancer	0.000471	0.000866	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000467	0.00252	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.000462	0.00249	CbGpPWpGaD
Methylprednisolone—Vomiting—Epirubicin—liver cancer	0.000458	0.000841	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—liver cancer	0.000456	0.000837	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—liver cancer	0.000454	0.000834	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—liver cancer	0.000454	0.000833	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000453	0.00244	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000452	0.00244	CbGpPWpGaD
Methylprednisolone—Headache—Epirubicin—liver cancer	0.000451	0.000828	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—liver cancer	0.000451	0.00243	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.000448	0.00242	CbGpPWpGaD
Methylprednisolone—Dizziness—Doxorubicin—liver cancer	0.000441	0.000809	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.000437	0.00236	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000436	0.00235	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.00043	0.00232	CbGpPWpGaD
Methylprednisolone—Nausea—Epirubicin—liver cancer	0.000428	0.000785	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000424	0.00229	CbGpPWpGaD
Methylprednisolone—Vomiting—Doxorubicin—liver cancer	0.000424	0.000778	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.000421	0.00227	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.00042	0.00227	CbGpPWpGaD
Methylprednisolone—Rash—Doxorubicin—liver cancer	0.00042	0.000771	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—liver cancer	0.00042	0.000771	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—liver cancer	0.000417	0.000766	CcSEcCtD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000413	0.00223	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00041	0.00221	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000406	0.00219	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000403	0.00217	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000402	0.00217	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000396	0.00214	CbGpPWpGaD
Methylprednisolone—Nausea—Doxorubicin—liver cancer	0.000396	0.000727	CcSEcCtD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000394	0.00212	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000391	0.00211	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.000379	0.00204	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000375	0.00202	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000375	0.00202	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000366	0.00197	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000362	0.00195	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000361	0.00195	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000357	0.00193	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000353	0.0019	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000346	0.00187	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000341	0.00184	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000337	0.00182	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000336	0.00181	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000332	0.00179	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000317	0.00171	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000317	0.00171	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.00031	0.00167	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000305	0.00164	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000301	0.00162	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000297	0.0016	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000295	0.00159	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000284	0.00153	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000282	0.00152	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000279	0.00151	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—liver cancer	0.000276	0.00149	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000276	0.00149	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000276	0.00149	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000274	0.00148	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000269	0.00145	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NR1H4—liver cancer	0.000268	0.00144	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000264	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000263	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000263	0.00142	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NR1I3—liver cancer	0.000263	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL2—liver cancer	0.000263	0.00142	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.00026	0.0014	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000258	0.00139	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000258	0.00139	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000256	0.00138	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000252	0.00136	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000252	0.00136	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000241	0.0013	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—liver cancer	0.000239	0.00129	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000239	0.00129	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000227	0.00122	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000223	0.0012	CbGpPWpGaD
Methylprednisolone—Prednisone—ALB—liver cancer	0.000221	0.131	CrCbGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000219	0.00118	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000216	0.00117	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP2E1—liver cancer	0.000211	0.125	CrCbGaD
Methylprednisolone—Dexamethasone—CYP1A1—liver cancer	0.000209	0.123	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000207	0.00112	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000205	0.00111	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000202	0.00109	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000199	0.00107	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000199	0.00107	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000195	0.00105	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—liver cancer	0.000193	0.00104	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—liver cancer	0.000191	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UGDH—liver cancer	0.000191	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000184	0.000994	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HNF4A—liver cancer	0.000182	0.000984	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000181	0.000976	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.00018	0.000973	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—EPT1—liver cancer	0.00018	0.000971	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000179	0.000963	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TAT—liver cancer	0.000171	0.00092	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000167	0.0009	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000166	0.000897	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000165	0.000888	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000165	0.000887	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000164	0.000885	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PSMD10—liver cancer	0.000159	0.00086	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PSMA4—liver cancer	0.000159	0.00086	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000158	0.00085	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000156	0.000839	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000148	0.000799	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000145	0.00078	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000133	0.000715	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00013	0.000701	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000126	0.000682	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000126	0.000681	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000125	0.000675	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000122	0.00066	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000122	0.000656	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000119	0.000644	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UGDH—liver cancer	0.000118	0.000636	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GLUL—liver cancer	0.000116	0.000626	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CPT1B—liver cancer	0.000116	0.000626	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NR1H4—liver cancer	0.000112	0.000603	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—EPT1—liver cancer	0.000111	0.000598	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00011	0.000595	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA3—liver cancer	0.00011	0.000593	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—H2AFX—liver cancer	0.000108	0.000581	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000106	0.000571	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TAT—liver cancer	0.000105	0.000567	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000101	0.000547	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000101	0.000546	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA4—liver cancer	0.000101	0.000542	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA2—liver cancer	9.8e-05	0.000529	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARA—liver cancer	9.58e-05	0.000517	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA1—liver cancer	9.45e-05	0.00051	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	9.45e-05	0.00051	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	9.38e-05	0.000506	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	9.37e-05	0.000506	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAT2—liver cancer	9.35e-05	0.000504	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDOB—liver cancer	8.96e-05	0.000483	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK14—liver cancer	8.85e-05	0.000477	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR1—liver cancer	8.68e-05	0.000468	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	8.61e-05	0.000464	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CRABP1—liver cancer	8.55e-05	0.000461	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	8.55e-05	0.000461	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	8.33e-05	0.000449	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—liver cancer	7.92e-05	0.000427	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPGDS—liver cancer	7.47e-05	0.000403	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CPT1B—liver cancer	7.15e-05	0.000385	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GLUL—liver cancer	7.15e-05	0.000385	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—liver cancer	7.14e-05	0.000385	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	7.03e-05	0.000379	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NR1H4—liver cancer	6.89e-05	0.000372	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA3—liver cancer	6.77e-05	0.000365	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PSMA4—liver cancer	6.66e-05	0.000359	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PSMD10—liver cancer	6.66e-05	0.000359	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GOT2—liver cancer	6.48e-05	0.000349	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	6.35e-05	0.000343	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA4—liver cancer	6.2e-05	0.000334	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2E1—liver cancer	6.09e-05	0.000329	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA2—liver cancer	6.04e-05	0.000326	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA1—liver cancer	5.82e-05	0.000314	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAT2—liver cancer	5.76e-05	0.000311	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	5.74e-05	0.00031	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYCS—liver cancer	5.7e-05	0.000307	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GOT1—liver cancer	5.59e-05	0.000302	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GGT1—liver cancer	5.59e-05	0.000302	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDOB—liver cancer	5.52e-05	0.000298	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CRABP1—liver cancer	5.27e-05	0.000284	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—liver cancer	5.02e-05	0.000271	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—liver cancer	4.95e-05	0.000267	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—liver cancer	4.62e-05	0.000249	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPGDS—liver cancer	4.6e-05	0.000248	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—liver cancer	4.52e-05	0.000244	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A1—liver cancer	4.38e-05	0.000236	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PSMA4—liver cancer	4.1e-05	0.000221	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PSMD10—liver cancer	4.1e-05	0.000221	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—liver cancer	4.08e-05	0.00022	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARA—liver cancer	4e-05	0.000216	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GOT2—liver cancer	3.99e-05	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2E1—liver cancer	3.75e-05	0.000202	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYCS—liver cancer	3.51e-05	0.000189	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GGT1—liver cancer	3.45e-05	0.000186	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GOT1—liver cancer	3.45e-05	0.000186	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—liver cancer	3.43e-05	0.000185	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—liver cancer	3.31e-05	0.000178	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—liver cancer	3.13e-05	0.000169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—liver cancer	3.1e-05	0.000167	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—liver cancer	3.05e-05	0.000165	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CD—liver cancer	3.01e-05	0.000163	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—liver cancer	2.98e-05	0.00016	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—liver cancer	2.84e-05	0.000153	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A1—liver cancer	2.7e-05	0.000145	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CB—liver cancer	2.63e-05	0.000142	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—liver cancer	2.51e-05	0.000136	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARA—liver cancer	2.47e-05	0.000133	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—liver cancer	2.11e-05	0.000114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—liver cancer	2.04e-05	0.00011	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CD—liver cancer	1.86e-05	0.0001	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—liver cancer	1.83e-05	9.89e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.62e-05	8.73e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—liver cancer	1.6e-05	8.64e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—liver cancer	1.31e-05	7.06e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—liver cancer	9.87e-06	5.32e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—liver cancer	8.06e-06	4.35e-05	CbGpPWpGaD
